583
Views
140
CrossRef citations to date
0
Altmetric
Review

Systems toxicology: applications of toxicogenomics, transcriptomics, proteomics and metabolomics in toxicology

, , , &
Pages 767-780 | Published online: 09 Jan 2014

References

  • Aardema MJ, MacGregor JT. Toxicology and genetic toxicology in the new era of ‘toxicogenomics’: impact of ‘-omics’ technologies. Mutat. Res. 499(1), 13–25 (2002).
  • Waters M, Fostel J. Toxicogenomics and systems toxicology: aims and prospects. Nature Rev. Genet. 5(12), 936–948 (2004).
  • Merrick BA, Bruno ME. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity. Curr. Opin. Mol. Ther. 6(6), 600–607 (2004).
  • Orphanides G, Kimber I. Toxicogenetics: applications and opportunities. Toxicol. Sci. 75(1), 1–6 (2003).
  • Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270(5235), 467–470 (1995).
  • Lockhart DJ, Dong H, Byrne MC et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotechnol. 14(13), 1675–1680 (1996).
  • Spellman PT, Sherlock G, Zhang MQ et al. Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol. Biol. Cell 9(12), 3273–3297 (1998).
  • DeRisi J, Penland L, Brown PO et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14(4), 457–460 (1996).
  • DeRisi JL, Iyer VR, Brown PO. Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278(5338), 680–686 (1997).
  • Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA 95(25), 14863–14868 (1998).
  • Lockhart DJ, Winzeler EA. Genomics, gene expression and DNA arrays. Nature 405(6788), 827–836 (2000).
  • Heijne WH, Stierum RH, Slijper M, van Bladeren PJ, van Ommen B. Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach. Biochem. Pharmacol. 65(5), 857–875 (2003).
  • Heijne WH, Slitt AL, van Bladeren PJ et al. Bromobenzene-induced hepatotoxicity at the transcriptome level. Toxicol. Sci. 79(2), 411–422 (2004).
  • Heinloth AN, Irwin RD, Boorman GA et al. Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol. Sci. 80(1), 193–202 (2004).
  • Rasmussen HH, Mortz E, Mann M, Roepstorff P, Celis JE. Identification of transformation sensitive proteins recorded in human two-dimensional gel protein databases by mass spectrometric peptide mapping alone and in combination with microsequencing. Electrophoresis 15(3–4), 406–416 (1994).
  • Shevchenko A, Jensen ON, Podtelejnikov AV et al. Linking genome and proteome by mass spectrometry: large-scale identification of yeast proteins from two dimensional gels. Proc. Natl Acad. Sci. USA 93(25), 14440–14445 (1996).
  • Shaw AC, Rossel Larsen M, Roepstorff P et al. Mapping and identification of interferon γ-regulated HeLa cell proteins separated by immobilized pH gradient two-dimensional gel electrophoresis. Electrophoresis 20(4–5), 984–993 (1999).
  • Fountoulakis M, Berndt P, Boelsterli UA et al. Two-dimensional database of mouse liver proteins: changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol. Electrophoresis 21(11), 2148–2161 (2000).
  • Kaji H, Tsuji T, Mawuenyega KG et al. Profiling of Caenorhabditis elegans proteins using two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21(9), 1755–1765 (2000).
  • Stults JT. Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS). Curr. Opin. Struct. Biol. 5(5), 691–698 (1995).
  • Liang X, Bai J, Liu YH, Lubman DM. Characterization of SDS-PAGE-separated proteins by matrix-assisted laser desorption/ionization mass spectrometry. Anal. Chem. 68(6), 1012–1018 (1996).
  • Borrebaeck CA, Ekstrom S, Hager AC et al. Protein chips based on recombinant antibody fragments: a highly sensitive approach as detected by mass spectrometry. Biotechniques 30(5), 1126–1130, 1132 (2001).
  • Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2(2), RESEARCH0004 (2001).
  • Han DK, Eng J, Zhou H, Aebersold R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nature Biotechnol. 19(10), 946–951 (2001).
  • Gygi SP, Rist B, Gerber SA et al. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nature Biotechnol. 17(10), 994–999 (1999).
  • Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21(6), 1164–1177 (2000).
  • Verhoeckx KC, Bijlsma S, de Groene EM et al. A combination of proteomics, principal component analysis and transcriptomics is a powerful tool for the identification of biomarkers for macrophage maturation in the U937 cell line. Proteomics 4(4), 1014–1028 (2004).
  • Wetmore BA, Merrick BA. Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicol. Pathol. 32(6), 619–642 (2004).
  • Nicholson JK, Lindon JC, Holmes E. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29(11), 1181–1189 (1999).
  • Holmes E, Nicholson JK, Tranter G. Metabonomic characterization of genetic variations in toxicological and metabolic responses using probabilistic neural networks. Chem. Res. Toxicol. 14(2), 182–191 (2001).
  • Gartland KP, Beddell CR, Lindon JC, Nicholson JK. Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. Mol. Pharmacol. 39(5), 629–642 (1991).
  • Robertson JD, Orrenius S. Molecular mechanisms of apoptosis induced by cytotoxic chemicals. Crit. Rev. Toxicol. 30(5), 609–627 (2000).
  • Fielden MR, Matthews JB, Fertuck KC, Halgren RG, Zacharewski TR. In silico approaches to mechanistic and predictive toxicology: an introduction to bioinformatics for toxicologists. Crit. Rev. Toxicol. 32(2), 67–112 (2002).
  • Brazma A, Vilo J. Gene expression data analysis. FEBS Lett. 480(1), 17–24 (2000).
  • Draghici S. Data analysis tools for DNA microarrays. CRC Press Ltd., London, UK, (2003).
  • Afshari CA, Nuwaysir EF, Barrett JC. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res. 59(19), 4759–4760 (1999).
  • Nuwaysir EF, Bittner M, Trent J, Barrett JC, Afshari CA. Microarrays and toxicology: the advent of toxicogenomics. Mol. Carcinog. 24(3), 153–159 (1999).
  • Cunningham MJ, Liang S, Fuhrman S, Seilhamer JJ, Somogyi R. Gene expression microarray data analysis for toxicology profiling. Ann. NY Acad. Sci. 919, 52–67 (2000).
  • Rockett JC, Dix DJ. Application of DNA arrays to toxicology. Environ. Health Perspect. 107(8), 681–685 (1999).
  • Rockett JC, Dix DJ. DNA arrays: technology, options and toxicological applications. Xenobiotica 30(2), 155–177 (2000).
  • Pennie WD, Tugwood JD, Oliver GJ, Kimber I. The principles and practice of toxigenomics: applications and opportunities. Toxicol. Sci. 54(2), 277–283 (2000).
  • Pennie WD, Woodyatt NJ, Aldridge TC, Orphanides G. Application of genomics to the definition of the molecular basis for toxicity. Toxicol. Lett. 120(1–3), 353–358 (2001).
  • Steiner S, Anderson NL. Expression profiling in toxicology – potentials and limitations. Toxicol. Lett. 112–113, 467–471 (2000).
  • Hamadeh HK, Amin RP, Paules RS, Afshari CA. An overview of toxicogenomics. Curr. Issues Mol. Biol. 4(2), 45–56 (2002).
  • Fielden MR, Zacharewski TR. Challenges and limitations of gene expression profiling in mechanistic and predictive toxicology. Toxicol. Sci. 60(1), 6–10 (2001).
  • Bulera SJ, Eddy SM, Ferguson E et al. RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 33(5), 1239–1258 (2001).
  • Waring JF, Jolly RA, Ciurlionis R et al. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. 175(1), 28–42 (2001).
  • Huang Q, Dunn RT II, Jayadev S et al. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol. Sci. 63(2), 196–207 (2001).
  • Gerhold D, Lu M, Xu J et al. Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol. Genomics 5(4), 161–170 (2001).
  • Reilly TP, Bourdi M, Brady JN et al. Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem. Biophys. Res. Commun. 282(1), 321–328 (2001).
  • Frueh FW, Hayashibara KC, Brown PO, Whitlock JP Jr. Use of cDNA microarrays to analyze dioxin-induced changes in human liver gene expression. Toxicol. Lett. 122(3), 189–203 (2001).
  • Hamadeh HK, Bushel PR, Jayadev S et al. Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67(2), 219–231 (2002).
  • Ezendam J, Staedtler F, Pennings J et al. Toxicogenomics of subchronic hexachlorobenzene exposure in Brown Norway rats. Environ. Health Perspect. 112(7), 782–791 (2004).
  • Hebbar V, Shen G, Hu R et al. Toxicogenomics of resveratrol in rat liver. Life Sci. 76(20), 2299–2314 (2005).
  • Gartland KP, Eason CT, Wade KE, Bonner FW, Nicholson JK. Proton NMR spectroscopy of bile for monitoring the excretion of endogenous and xenobiotic metabolites: application to para-aminophenol. J. Pharm. Biomed. Anal. 7(6), 699–707 (1989).
  • Holmes E, Nicholson JK, Bonner FW et al. Mapping the biochemical trajectory of nephrotoxicity by pattern recognition of NMR urinanalysis. NMR Biomed. 5(6), 368–372 (1992).
  • Holmes E, Bonner FW, Sweatman BC et al. Nuclear magnetic resonance spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by mercury(II) chloride and 2-bromoethanamine. Mol. Pharmacol. 42(5), 922–930 (1992).
  • Holmes E, Nicholls AW, Lindon JC et al. Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed. 11(4–5), 235–244 (1998).
  • Beckwith-Hall BM, Nicholson JK, Nicholls AW et al. Nuclear magnetic resonance spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem. Res. Toxicol. 11(4), 260–272 (1998).
  • Waters NJ, Holmes E, Waterfield CJ, Farrant RD, Nicholson JK. NMR and pattern recognition studies on liver extracts and intact livers from rats treated with α-naphthylisothiocyanate. Biochem. Pharmacol. 64(1), 67–77 (2002).
  • Heijne WH, Lamers RJ, van Bladeren PJ et al. Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis. Toxol. Pathol. 33(4), 425–433 (2005).
  • Heijne WH, Jonker D, Stierum RH, Ommen BV, Groten JP. Toxicogenomic analysis of gene expression changes in rat liver after a 28-day oral benzene exposure. Mutat. Res. 575(1–2), 85–101 (2005).
  • Burczynski ME, McMillian M, Ciervo J et al. Toxicogenomics-based discrimination of toxic mechanism in HepG2 human hepatoma cells. Toxicol. Sci. 58(2), 399–415 (2000).
  • Bartosiewicz MJ, Jenkins D, Penn S, Emery J, Buckpitt A. Unique gene expression patterns in liver and kidney associated with exposure to chemical toxicants. J. Pharmacol. Exp. Ther. 297(3), 895–905 (2001).
  • Hamadeh HK, Bushel PR, Jayadev S et al. Predicton of compound signature using high density gene expression profiling. Toxicol. Sci. 67, 232–240 (2002).
  • Cutler P, Birrell H, Haran M et al. Proteomics in pharmaceutical research and development. Biochem. Soc. Trans. 27(4), 555–559 (1999).
  • Joo WA, Sul D, Lee DY, Lee E, Kim CW. Proteomic analysis of plasma proteins of workers exposed to benzene. Mutat. Res. 558(1–2), 35–44 (2004).
  • Kleno T, Kiehr B, Baunsgaard D, Sidelmann U. Combination of ‘omics’ data to investigate the mechanism(s) of hydrazine-induced hepatotoxicity in rats and to identify potential biomarkers. Biomarkers 9(2), 116–138 (2004).
  • Rockett JC, Burczynski ME, Fornace AJ, Herrmann PC, Krawetz SA, Dix DJ. Surrogate tissue analysis: monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells. Toxicol. Appl. Pharmacol. 194, 189–199 (2004).
  • Stierum RH, Heijne WH, Kienhuis AS, van Ommen B, Groten JP. Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals in vitro and in vivo. Toxicol. Appl. Pharm. 207(2 Suppl.), 179–188 (2005).
  • Pennie W, Pettit SD, Lord PG. Toxicogenomics in risk assessment: an overview of an HESI collaborative research program. Environ. Health Perspect. 112(4), 417–419 (2004)
  • Balls M, Goldberg AM, Fentem JH et al. The three Rs: the way forward: the report and recommendations of ECVAM Workshop 11. Altern. Lab. Anim. 23(6), 838–866 (1995).
  • Luttringer O, Theil FP, Lave T et al. Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes. Biochem. Pharmacol. 64(11), 1637–1650 (2002).
  • Jessen BA, Mullins JS, De Peyster A, Stevens GJ. Assessment of hepatocytes and liver slices as in vitro test systems to predict in vivo gene expression. Toxicol. Sci. 75(1), 208–222 (2003).
  • Baker TK, Carfagna MA, Gao H et al. Temporal gene expression analysis of monolayer cultured rat hepatocytes. Chem. Res. Toxicol. 14(9), 1218–1231 (2001).
  • Boess F, Kamber M, Romer S et al. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol. Sci. 73(2), 386–402 (2003).
  • Harris AJ, Dial SL, Casciano DA. Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. Mutat. Res. 549(1–2), 79–99 (2004).
  • O’Brien PJ, Chan K, Silber PM. Human and animal hepatocytes in vitro with extrapolation in vivo. Chem. Biol. Interact. 150(1), 97–114 (2004).
  • Dunn JC, Yarmush ML, Koebe HG, Tompkins RG. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J. 3(2), 174–177 (1989).
  • Jaeschke H. Are cultured liver cells the right tool to investigate mechanisms of liver disease or hepatotoxicity? Hepatology 38(4), 1053–1055 (2003).
  • Bartosiewicz M, Trounstine M, Barker D, Johnston R, Buckpitt A. Development of a toxicological gene array and quantitative assessment of this technology. Arch. Biochem. Biophys. 376(1), 66–73 (2000).
  • Waring JF, Ciurlionis R, Jolly RA, Heindel M, Ulrich RG. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120(1–3), 359–368 (2001).
  • de Longueville F, Atienzar FA, Marcq L et al. Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol. Sci. 75(2), 378–392 (2003).
  • Ruepp SU, Tonge RP, Shaw J, Wallis N, Pognan F. Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol. Sci. 65(1), 135–150 (2002).
  • Prat O, Berenguer F, Malard V et al. Transcriptomic and proteomic responses of human renal HEK293 cells to uranium toxicity. Proteomics 5(1), 297–306 (2005).
  • Izzotti A, Bagnasco M, Cartiglia C, Longobardi M, De Flora S. Proteomic analysis as related to transcriptome data in the lung of chromium(VI)-treated rats. Int. J. Oncol. 24(6), 1513–1522 (2004).
  • Andrew AS, Warren AJ, Barchowsky A et al. Genomic and proteomic profiling of responses to toxic metals in human lung cells. Environ. Health Perspect. 111(6), 825–835 (2003).
  • Cunningham ML, Bogdanffy MS, Zacharewski TR, Hines RN. Workshop overview: use of genomic data in risk assessment. Toxicol. Sci. 73(2), 209–215 (2003).
  • Irizarry RA, Warren D, Spencer F et al. Multiple-laboratory comparison of microarray platforms. Nature Methods 2(6), 477 (2005).

Websites

  • Microarray Gene Expression Data Society – MGED Society www.mged.org (Viewed September 2005)
  • Gene Ontology http://geneontology.org (Viewed September 2005)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.